Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
$2.3100
+0.0400 ( +0.44% ) 79.9K
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derivedĀ from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Market Data
Open
$2.3100
Previous close
$2.2700
Volume
79.9K
Market cap
$31.19M
Day range
$2.0850 - $2.3250
52 week range
$1.0400 - $3.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Dec 09, 2024 |
4 | Insider transactions | 1 | Dec 05, 2024 |
4 | Insider transactions | 1 | Dec 05, 2024 |
4 | Insider transactions | 1 | Dec 05, 2024 |
4 | Insider transactions | 1 | Dec 05, 2024 |
8-k | 8K-related | 15 | Nov 12, 2024 |
10-q | Quarterly Reports | 58 | Nov 08, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
8-k | 8K-related | 15 | Nov 06, 2024 |
4 | Insider transactions | 1 | Nov 05, 2024 |